(Q42873615)

9 November 2017

Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age. (English)

1 reference

9 November 2017

Jeffrey S Nye

3

0 references

author name string

Ihab G Girgis

1

1 reference

9 November 2017

Partha Nandy

2

1 reference

9 November 2017

Lisa Ford

4

1 reference

9 November 2017

Surya Mohanty

5

1 reference

9 November 2017

Steven Wang

6

1 reference

9 November 2017

Stefan Ochalski

7

1 reference

9 November 2017

Marielle Eerdekens

8

1 reference

9 November 2017

Eugène Cox

9

1 reference

9 November 2017

29 September 2010

1 reference

9 November 2017

1 reference

9 November 2017

51

1 reference

9 November 2017

1954-1962

1 reference

9 November 2017

10

1 reference

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy

9 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Anticonvulsant serum levels are useful only if the physician appropriately uses them: an assessment of the impact of providing serum level data to physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Efficacy and safety of topiramate in infants according to epilepsy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Topiramate in add-on therapy: results from an open-label, observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Spotlight on topiramate in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Population pharmacokinetic studies in pediatrics: issues in design and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Zonisamide monotherapy with once-daily dosing in children with cryptogenic localization-related epilepsies: clinical effects and pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

The use of antiepileptic drugs--principles and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

Anticonvulsant blood levels: historical review with a pediatric focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02598.X

10.1111/J.1528-1167.2010.02598.X

21 January 2018

Identifiers

DOI

1 reference

9 November 2017

1 reference